MKTX Congressional Stock Trades
MarketAxess Holdings, Inc.
Last disclosed trade Apr 9
Every disclosed trade in MKTX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every financials stock Congress trades.
Sample · the intelligence layer
Rohit Khanna · Bought $MKTX · Apr 26 · $1K–$15K
Managed-account penalty applied (x 0.20): filings dominated by trust or wealth-manager activity are discounted.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $MKTX
Get notified when any member of Congress trades $MKTX. Free, no card, no spam.
The record on $MKTX
Coldpine has parsed 5 disclosed trades in $MKTX by 3 members of Congress, drawn from 5 periodic transaction reports dated Apr 26, 2024 through Apr 9, 2026. All of them came from House members, all filed by Democrats.
Of the 5 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 28 days. The longest was 40 days: a $MKTX sale by Josh Gottheimer dated Apr 9, 2026, disclosed May 19, 2026. How late filing is measured across all of Congress is in the late-filers study.
5 of the 5 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Julie Johnson filed the most $MKTX purchases (1), and Josh Gottheimer the most sales (1).
Activity peaked in 2025 with 2 trades.
Members who trade MKTX
Recent disclosed trades in MKTX
| Date | Member | Type | Amount |
|---|---|---|---|
| Apr 9 | Josh Gottheimer(NJ) | sell | $1K–$15K |
| Feb 12 | Julie Johnson(TX) | sell | $1K–$15K |
| Jan 15 | Julie Johnson(TX) | buy | $1K–$15K |
| Jul 2 | Rohit Khanna(CA) | sell | $1K–$15K |
| Apr 26 | Rohit Khanna(CA) | buy | $1K–$15K |
From Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →